Satisfaction with onychomycosis treatment: Pulse versus continuous dosing

Erin M. Warshaw, Thomas Bowman, Myron A. Bodman, John J. Kim, Stefanie Silva, Susan D. Mathias

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The purpose of this study, which involved two dermatology clinics and two podiatric medical clinics, was to determine whether a difference exists in patient-reported satisfaction and compliance between continuous terbinafine therapy and pulse-dose itraconazole therapy for the treatment of toenail onychomycosis. Patients in this multicenter, open-label, cross-sectional study had previously completed treatment with either oral terbinafine or oral itraconazole for toenail onychomycosis. Patients were interviewed by telephone to assess clinical outcomes, compliance, and satisfaction with treatment; clinical data were collected by medical chart review. Patients reported significantly greater ease and convenience of treatment and higher overall satisfaction with continuous terbinafine therapy compared with pulse-dose itraconazole therapy.

Original languageEnglish (US)
Pages (from-to)373-379
Number of pages7
JournalJournal of the American Podiatric Medical Association
Issue number5
StatePublished - 2003


Dive into the research topics of 'Satisfaction with onychomycosis treatment: Pulse versus continuous dosing'. Together they form a unique fingerprint.

Cite this